Delivery Order SPE2DX15D2211-BF83
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,589.18 Firm Fixed Price Delivery Order contract is for a Prime Vendor Pharmacy Branch in Philadelphia and has an ultimate completion date of September 2, 2016. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $165,596.96, is for a prime vendor pharmaceutical branch in Philadelphia. It is a delivery order contract with a firm fixed price pricing type, with a period of performance ending on September 22, 2016. The contract does not have a set-aside designation. Amerisourcebergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $94,100.89 contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, and has an ultimate completion date of May 25, 2017. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,722.00 Delivery Order contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of October 12, 2018. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $111,936.41 firm fixed price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with an ultimate completion date of April 29, 2015. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $78,283.52, is for a Prime Vendor Pharmaceutical Branch in Philadelphia. It is a Firm Fixed Price delivery order contract that runs through September 6, 2016. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $251,026.10, is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 30, 2016. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $283,546.95 firm-fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of August 26, 2016. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $83,085.46 firm fixed price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has an ultimate completion date of August 2, 2016 and was awarded on July 14, 2016. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $109,857.60 firm fixed-price delivery order is for the Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of June 7, 2016. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- SPE2DX15D2211Indefinite Delivery Contract
- SPE2DX15D2211-BF83Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $434,549.27 delivery order contract is for a Prime Vendor Pharmaceutical program in the Philadelphia region and has a completion date of September 22, 2015. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $434.5k | 9/21/15 |